A modification method for improving the activity of polyglutamic acid and its product and application

By reacting alkyl oxyhydroxide quaternary ammonium salt with polyglutamic acid to prepare cationic polyglutamic acid, the problem of poor antibacterial and tyrosinase inhibition of natural polyglutamic acid is solved, and effective inhibition of bacteria is achieved Bacteria and antioxidant, providing whitening and anti-aging effects while maintaining skin-free irritation.

CN118725291BActive Publication Date: 2024-11-05QINGDAO SUBO BIOTECHNOLOGY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411223694.5
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-09-03
Publication Date
2024-11-05
Estimated Expiration
2044-09-03

AI Technical Summary

Technical Problem

Natural polyglutamic acid lacks antibacterial properties and inhibits tyrosinase activity in the cosmetics field, and cannot meet the whitening and anti-aging effects of the product when used alone.

Method used

Cationic polyglutamic acid is prepared by reacting alkyl oxyhydroxide quaternary ammonium salt with polyglutamic acid, which improves its antibacterial activity, antioxidant activity and tyrosinase inhibitory activity, and forms a new cationic polyglutamic acid.

Benefits of technology

Effective antibacterial treatment against E. coli and Staphylococcus aureus is achieved, antioxidant capacity is enhanced, melanin production is reduced, whitening and anti-aging effects are provided, and it is not irritating in the skin.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure SMS_1
    Figure SMS_1
  • Figure SMS_2
    Figure SMS_2
  • Figure SMS_3
    Figure SMS_3
Patent Text Reader

Abstract

The present invention relates to the technical field of polyglutamic acid, and in particular to a modification method for improving the activity of polyglutamic acid, and its products and applications. The modification method comprises the following steps: (1) adding epichlorohydrin to N, N-dimethyldecylamine, the mass ratio of N, N-dimethyldecylamine to epichlorohydrin is 1.5:1-3:1, heating and stirring the reaction at 45-55°C for 2-6h to obtain an epoxyalkyl quaternary ammonium salt; (2) adding the epoxyalkyl quaternary ammonium salt prepared in step (1) to a polyglutamic acid aqueous solution for reaction, the mass ratio of polyglutamic acid to the epoxyalkyl quaternary ammonium salt is 4:1-6:1, controlling the temperature at 50-70°C, reacting for 48-72h, and preparing cationic polyglutamic acid. The modification method of the present invention is simple and easy, the product has good antibacterial effect, and has no skin irritation, has a certain scavenging rate for DPPH free radicals, and has a high inhibition rate for tyrosinase.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of polyglutamic acid, and in particular to a modification method for improving the activity of polyglutamic acid, and a product and application thereof. Background Art

[0002] Polyglutamic acid only exists in marine organisms such as jellyfish and natto in nature. It is the main substance that supports jellyfish to survive in the ocean with high pressure and salinity, and is also the main component of the viscous colloid of natto. Polyglutamic acid molecules contain super hydrophilic carboxyl groups, which give them extremely strong moisturizing ability, moisturizing the stratum corneum of the skin and improving the skin's self-moisturizing ability; polyglutamic acid can form a protective film on the skin surface, increase skin elasticity, and repair the skin barrier. Therefore, polyglutamic acid is widely used in the fields of cosmetics and medical dressings.

[0003] Natural polyglutamic acid does not have antibacterial properties, and its efficacy in the field of cosmetics is single, which cannot meet product requirements well. The invention with publication number CN 111704856 A provides a γ-polyglutamic acid-polycationic complex, which is formed by charge interaction between negatively charged low molecular weight γ-polyglutamic acid and positively charged polycationic compounds. The γ-polyglutamic acid-polycationic complex can adhere to the surface of medical devices and isolate the growth of microorganisms on the surface of the device. However, this method does not change the molecular structure of polyglutamic acid, and its antibacterial and anti-bacterial adhesion effects mainly come from the antibacterial effect of polylysine or chitosan quaternary ammonium salt. Polyglutamic acid does not have antibacterial efficacy when used alone.

[0004] Studies have shown that natural polyglutamic acid can also reduce the production of melanin by inhibiting the activity of tyrosinase, and can be used to manufacture cosmetics with whitening and freckle removal functions. The invention with publication number CN 114681358 A synergistically improves the inhibitory effect on the activity of tyrosinase by compounding polyglutamic acid, 4-n-butylresorcinol, glutathione, nicotinamide and ascorbic acid ethyl ether. This method requires the addition of multiple whitening ingredients to achieve a synergistic whitening effect. When polyglutamic acid is used alone, the inhibitory effect on the activity of tyrosinase is not improved. Summary of the invention

[0005] Aiming at the problem that the antibacterial effect and the inhibition of tyrosinase activity when polyglutamic acid is used alone are not ideal, the present invention provides a modification method for improving the activity of polyglutamic acid, a product and an application thereof. Cationic polyglutamic acid is prepared by reacting an epoxyalkyl quaternary ammonium salt with polyglutamic acid. The method is simple and easy to implement, the product has a good antibacterial effect and is non-irritating to the skin; the polyglutamic acid has a certain scavenging rate for DPPH free radicals, and is used in cosmetics with anti-aging effects to scavenge free radicals and improve the antioxidant capacity of cosmetics; the polyglutamic acid has a high inhibition rate for tyrosinase, inhibits tyrosinase activity, reduces melanin generation, and can be used in cosmetics with whitening effects to whiten the skin.

[0006] In a first aspect, the present invention provides a modification method for improving the activity of polyglutamic acid, that is, a method for preparing cationic polyglutamic acid, comprising the following steps:

[0007] (1) adding epichlorohydrin to N,N-dimethyldecylamine, wherein the mass ratio of N,N-dimethyldecylamine to epichlorohydrin is 1.5:1-3:1, heating and stirring at 45-55° C. for 2-6 hours to obtain an epoxyalkyl quaternary ammonium salt;

[0008] (2) adding the epoxyalkyl quaternary ammonium salt prepared in step (1) to the polyglutamic acid aqueous solution for reaction, wherein the mass ratio of polyglutamic acid to the epoxyalkyl quaternary ammonium salt is 4:1-6:1, the temperature is controlled at 50-70° C., and the reaction is carried out for 48-72 hours to prepare cationic polyglutamic acid.

[0009] Furthermore, the molecular weight of polyglutamic acid is 700,000-1.5 million.

[0010] Furthermore, after the reaction in step (1) is completed, the reaction mixture is precipitated with cyclohexane and dried under reduced pressure to obtain an epoxyalkyl quaternary ammonium salt.

[0011] Furthermore, after the reaction in step (2) is completed, ethanol is used for precipitation, washing, and vacuum drying to obtain cationic polyglutamic acid.

[0012] In a second aspect, the present invention provides a cationic polyglutamic acid prepared by the above modification method.

[0013] In a third aspect, the present invention further provides a use of the above cationic polyglutamic acid in the preparation of cosmetics, wherein the cosmetics have whitening and / or anti-aging effects.

[0014] The beneficial effects of the present invention are:

[0015] The invention synthesizes a new cationic polyglutamic acid by performing molecular modification of a specific structure on polyglutamic acid, thereby improving the antibacterial activity, antioxidant activity and tyrosinase inhibition activity of the polyglutamic acid.

[0016] The cationic polyglutamic acid provided by the present invention has good antibacterial effects on both Escherichia coli and Staphylococcus aureus, and has no obvious skin irritation; the cationic polyglutamic acid has a certain scavenging rate for DPPH free radicals, and has a high inhibition rate for tyrosinase, thereby reducing melanin production. The cationic polyglutamic acid prepared by the present invention can be used in the field of cosmetics to improve the antioxidant capacity and whitening effect of cosmetics. DETAILED DESCRIPTION

[0017] In order to enable those skilled in the art to better understand the technical solutions in the present invention, the technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work should fall within the scope of protection of the present invention.

[0018] Example 1

[0019] A cationic polyglutamic acid is prepared by modifying polyglutamic acid with a molecular weight of 700,000 as a raw material (purchased from Wuhan Kangluda Biotechnology Co., Ltd.), and the specific modification method is as follows:

[0020] (1) 2 g of epichlorohydrin was added dropwise to 6 g of N,N-dimethyldecylamine, heated and stirred at 55°C for 2 h, and then precipitated with cyclohexane and dried under reduced pressure to obtain an epoxyalkyl quaternary ammonium salt;

[0021] (2) Weigh 2 g of polyglutamic acid and dissolve it in 90 mL of deionized water, add 0.5 g of the epoxyalkyl quaternary ammonium salt obtained in step (1), control the temperature at 50° C., react for 72 h, and after the reaction is completed, precipitate with ethanol, wash three times, and vacuum dry to obtain cationic polyglutamic acid, named G1.

[0022] Example 2

[0023] A cationic polyglutamic acid is prepared by modifying polyglutamic acid with a molecular weight of 700,000 as a raw material (purchased from Wuhan Kangluda Biotechnology Co., Ltd.), and the specific modification method is as follows:

[0024] (1) 2 g of epichlorohydrin was added dropwise to 3 g of N,N-dimethyldecylamine, heated and stirred at 45°C for 6 h, and then precipitated with cyclohexane and dried under reduced pressure to obtain an epoxyalkyl quaternary ammonium salt;

[0025] (2) Weigh 3 g of polyglutamic acid and dissolve it in 90 mL of deionized water, add 0.5 g of the epoxyalkyl quaternary ammonium salt obtained in step (1), control the temperature at 70°C, react for 48 hours, and after the reaction is completed, precipitate with ethanol, wash three times, and vacuum dry to obtain cationic polyglutamic acid, named G2.

[0026] Test Example 1 Staphylococcus aureus antibacterial test

[0027] Experimental basis: Appendix C4 of GB 15979-2002 Hygiene Standard for Disposable Sanitary Products.

[0028] Experimental conditions: temperature 19~21℃, relative humidity 50%~53%.

[0029] Experimental strain: Staphylococcus aureus (ATCC 6538) was tested by taking the fifth generation fresh slant culture, washing the bacterial lawn with 0.03 mol / L PBS, making the bacterial suspension uniform, and then diluting it with PBS to 5×10 5 The concentration of cfu / mL was used for later use.

[0030] Experimental steps: The cationic polyglutamic acid G1 and cationic polyglutamic acid G2 prepared in Example 1-2 and the polyglutamic acid raw material of Example 1 were dissolved in PBS buffer to prepare solutions with a concentration of 1 mg / mL, and were named X1, X2, and Y1 respectively.

[0031] Measure 4 portions of each of the X1, X2, and Y1 solutions into test tubes, with each solution volume of 5 mL. Add 100 μL of the above-mentioned PBS suspension of Staphylococcus aureus to each test tube, mix evenly, start timing, and act for 20 minutes. Use a pipette to take 0.5 mL of the test sample and put it into a test tube containing 5 mL of PBS, mix thoroughly, and make appropriate dilutions. Then take 0.5 mL of 2 to 3 dilutions, respectively, and place them on two plates. Pour 15 mL of Sabouraud agar medium cooled to 40 to 45 ° C, rotate the plate to make it fully uniform, turn the plate over after the agar solidifies, and culture at 35 ± 2 ° C for 72 hours to count the number of live colonies.

[0032] Data processing method: The experiment was repeated 3 times, and the sample inhibition rate was calculated as follows:

[0033] Antibacterial rate (%) = (AB) / A×100%,

[0034] A and B are the average colony counts of the blank control and the average colony counts of the tested samples, respectively.

[0035] Evaluation criteria: 50%≤inhibition rate<90%, the product has antibacterial effect; inhibition rate≥90%, the product has strong antibacterial effect.

[0036] The antibacterial effects of the tested samples on Staphylococcus aureus are shown in Table 1. It can be seen that the antibacterial rate of the unmodified polyglutamic acid sample Y1 (corresponding to the polyglutamic acid raw material of Example 1) is far below 50%, and has no antibacterial effect on Staphylococcus aureus; while the antibacterial rates of the modified tested samples X1 and X2 (corresponding to the cationic polyglutamic acids G1 and G2 prepared in Examples 1 and 2 of the present invention) on Staphylococcus aureus are far greater than 90%, indicating that the cationic polyglutamic acid of the present invention has a strong antibacterial effect on Staphylococcus aureus.

[0037] Table 1 Antibacterial effect of the tested samples on Staphylococcus aureus

[0038]

[0039] Test Example 2 Escherichia coli antibacterial test

[0040] Based on Appendix C4 of GB 15979-2002 “Hygiene Standard for Disposable Hygiene Products” and using Escherichia coli (ATCC 8099) as the experimental strain, the antibacterial test of cationic polyglutamic acid on Escherichia coli was carried out. The specific test method and data processing method are the same as those in Test Example 1.

[0041] The antibacterial effects of the tested samples on Escherichia coli are shown in Table 2. It can be seen that the antibacterial rate of the unmodified polyglutamic acid sample Y1 (corresponding to the polyglutamic acid raw material of Example 1) is far below 50%, and has no antibacterial effect on Escherichia coli; while the antibacterial rates of the modified samples X1 and X2 (corresponding to the cationic polyglutamic acids G1 and G2 prepared in Examples 1 and 2 of the present invention) are far greater than 90%, indicating that the cationic polyglutamic acid of the present invention has a strong antibacterial effect on Escherichia coli.

[0042] Table 2 Antibacterial effect of the tested samples on Escherichia coli

[0043]

[0044] Test Example 3 Acute skin irritation test

[0045] Experimental conditions: temperature 16~26℃, relative humidity 40%~70%.

[0046] Experimental animal information: Species, rabbit; Grade, New Zealand rabbit; Number of animals: 8, half male and half female (female New Zealand rabbits were not pregnant and had never given birth).

[0047] Experimental procedures: New Zealand rabbits were adapted to the laboratory animal room environment for 3 days. 24 hours before the experiment, the hair on both sides of the New Zealand rabbit's back spine was removed without damaging the epidermis. The hair removal range was about 3cm×3cm on the left and right sides. 0.5mL of the test sample (X1, X2, the preparation method is the same as that of test example 1) was applied directly to the left skin, and then covered with two layers of gauze of 2.5cm×2.5cm and one layer of cellophane, and then fixed with non-irritating tape and bandage. The right skin was used as a blank control. A closed test was used, and the application time was 4h. After the test, the residual 0.5mL was removed with warm water. The skin reaction at the application site was observed 1, 24, 48 and 72h after the removal of the test sample.

[0048] Scoring shall be carried out in accordance with "Table 1 Skin Irritation Reaction Scoring" in Chapter 6.4 of "Technical Specifications for Safety of Cosmetics" (2015 edition), with a comprehensive evaluation based on the average score of the test animals. The skin irritation intensity shall be determined based on the average of the highest scores at each observation time of 24h, 48h and 72h and in accordance with "Table 2 Skin Irritation Intensity Grading" in Chapter 6.4 of "Technical Specifications for Safety of Cosmetics" (2015 edition).

[0049] The results of the acute skin irritation test of each test sample on New Zealand rabbits are shown in Table 3 and Table 4. It can be seen that the modified test samples X1 and X2 (corresponding to the cationic polyglutamic acid G1 and G2 prepared in Example 1 and Example 2 of the present invention) are both non-irritating to the acute skin irritation of New Zealand rabbits.

[0050] Table 3 Acute skin irritation score of test sample X1 on New Zealand rabbits

[0051]

[0052] Note: The integral mean is rounded to 2 decimal places.

[0053] Table 4 Acute skin irritation score of test sample X2 on New Zealand rabbits

[0054]

[0055] Note: The integral mean is rounded to 2 decimal places.

[0056] Test Example 4 Tyrosinase Activity Inhibition Experiment

[0057] Experimental reagents: tyrosinase solution, prepared with sodium hydrogen phosphate-citrate buffer at pH 6.8, 100u / mL, prepared immediately before use;

[0058] Levodopa solution, prepared with sodium hydrogen phosphate-citrate buffer at pH 6.8, 1 mg / mL, stored in the dark;

[0059] Experimental steps: The test samples (cationic polyglutamic acid G1 of Example 1 and polyglutamic acid raw material of Example 1) were diluted with disodium hydrogen phosphate-citric acid buffer to form multi-level concentration samples. Use 10mL test tubes to set up sample tubes, sample background tubes, enzyme reaction tubes and solvent background tubes. Three parallel tubes need to be set up for each sample tube of each tested concentration of each test sample, and three parallel tubes need to be set up for the enzyme reaction tube. 1mL of sample solution of the same concentration was added to each sample tube and sample background tube, and 1mL of disodium hydrogen phosphate-citric acid buffer was added to the enzyme reaction tube and solvent background tube.

[0060] Add 0.5 mL of tyrosinase solution to each of the sample tube and the enzyme reaction tube. Replace the sample background tube and the solvent background tube with 0.5 mL of disodium hydrogen phosphate-citrate buffer. Mix the sample and tyrosinase thoroughly and incubate in a 37°C water bath for 10 minutes.

[0061] 2 mL of L-DOPA solution was added to each tube in turn, and the reaction time of each tube was controlled to be 5 minutes. The reaction solution of each tube was immediately transferred to a cuvette, and the absorbance value was measured at 475 nm.

[0062] The tyrosinase inhibition rate was calculated according to the following formula:

[0063] ,

[0064] Among them, T is the absorbance of the sample tube, that is, the absorbance of the solution after the sample reacts with tyrosinase; T0 is the absorbance of the sample background tube; C is the average of the three absorbances of the enzyme reaction tube, that is, the absorbance of the reaction of tyrosinase and DOPA when no sample is added; C0 is the absorbance of the solvent background tube.

[0065] The inhibitory effects of each test sample on tyrosinase are shown in Table 5. It can be seen that when the test sample concentration is 1 mg / mL, the tyrosinase inhibition rate of cationic polyglutamic acid G1 is 44.97%, which is higher than 39.81% of the unmodified polyglutamic acid raw material; when the test sample concentration is 2 mg / mL, the tyrosinase inhibition rate of cationic polyglutamic acid G1 is 63.03%, which is higher than 52.41% of the unmodified polyglutamic acid raw material. It can be seen that compared with the polyglutamic acid raw material, the tyrosinase inhibition rate of cationic polyglutamic acid is improved to a certain extent.

[0066] Table 5 Inhibitory effect of the tested samples on tyrosinase

[0067]

[0068] Test Example 5 Free Radical (DPPH) Scavenging Experiment

[0069] Experimental steps: The test samples (cationic polyglutamic acid G1 of Example 1 and polyglutamic acid raw material of Example 1) were diluted with water to form multi-level concentration samples. Use 10mL test tubes to set up sample tubes, sample background tubes, DPPH tubes and solvent background tubes. Three parallel tubes need to be set up for each test concentration of each test sample, and three parallel tubes need to be set up for the DPPH tube. Add 1mL of sample solution of the same concentration to each sample tube and sample background tube.

[0070] Fill all test tubes with 3 mL of water and mix well. Add 3 mL of 0.12 mg / mL DPPH ethanol solution to the sample tube and DPPH tube, replace the sample background tube and solvent background tube with 95% ethanol, shake gently, and let stand at room temperature for 5 minutes. Transfer the reaction solution in each tube into a 1 cm cuvette and measure the absorbance at 517 nm.

[0071] The DPPH free radical scavenging rate was calculated according to the following formula:

[0072] ,

[0073] Among them, T is the absorbance of the sample tube, that is, the absorbance of the solution after the sample reacts with DPPH; T0 is the absorbance of the sample background tube; C is the average of the three absorbances of the DPPH tube, that is, the absorbance of the DPPH solution when no sample is added; C0 is the absorbance of the solvent background tube.

[0074] The scavenging effects of the tested samples on DPPH radicals are shown in Table 6. It can be seen that when the concentration of the tested samples was 1 mg / mL, the DPPH radical scavenging rate of cationic polyglutamic acid G1 was 9.26%, which was higher than 6.45% of the unmodified polyglutamic acid raw material; when the concentration of the tested samples was 2 mg / mL, the DPPH radical scavenging rate of cationic polyglutamic acid G1 was 24.17%, which was much higher than 11.62% of the unmodified polyglutamic acid raw material; it can be seen that compared with the polyglutamic acid raw material, the DPPH radical scavenging rate of cationic polyglutamic acid was improved to a certain extent, and with the increase of the concentration of the tested samples, the DPPH radical scavenging rate of cationic polyglutamic acid was significantly improved, thereby improving the antioxidant capacity of the material.

[0075] Table 6 Scavenging effect of the tested samples on DPPH free radicals

[0076]

[0077] In summary, 1mg / mL cationic polyglutamic acid has a strong antibacterial effect on Escherichia coli and Staphylococcus aureus; and the results of the acute skin irritation test on New Zealand rabbits show that at this concentration, cationic polyglutamic acid has no skin irritation. When the concentration of cationic polyglutamic acid is increased to 2mg / mL, the inhibition rate of tyrosinase is 63.03%, which is higher than 52.41% of the unmodified polyglutamic acid raw material; the DPPH free radical scavenging rate is 24.17%, which is much higher than 11.62% of the unmodified polyglutamic acid raw material. The modification method for improving the activity of polyglutamic acid provided by the present invention can significantly enhance the antibacterial effect of polyglutamic acid, improve its inhibition rate of tyrosinase and scavenging rate of DPPH free radicals. The cationic polyglutamic acid product obtained after modification can be used in cosmetic products, providing certain antibacterial effects, inhibiting tyrosinase activity, reducing melanin production, and whitening skin; it can also scavenge free radicals and provide certain antioxidant capacity.

[0078] Although the present invention has been described in detail by way of preferred embodiments, the present invention is not limited thereto. Without departing from the spirit and essence of the present invention, a person of ordinary skill in the art may make various equivalent modifications or substitutions to the embodiments of the present invention, and such modifications or substitutions shall be within the scope of the present invention. Any person of ordinary skill in the art may easily conceive of changes or substitutions within the technical scope disclosed by the present invention, and such changes or substitutions shall be within the scope of protection of the present invention.

Claims

1. A modification method for improving the activity of polyglutamic acid, characterized in that: The steps include: (1) Add epichlorohydrin to N,N-dimethyldecylamine, with the mass ratio of N,N-dimethyldecylamine to epichlorohydrin being 1.5:1-3:1, and heat and stir at 45-55°C for 2-6 hours to obtain an epoxyalkyl quaternary ammonium salt; (2) Adding the epoxyalkyl quaternary ammonium salt prepared in step (1) to the polyglutamic acid aqueous solution for reaction, wherein the mass ratio of polyglutamic acid to epoxyalkyl quaternary ammonium salt is 4:1-6:1, controlling the temperature at 50-70°C, and reacting for 48-72h to prepare cationic polyglutamic acid.

2. The modification method according to claim 1, wherein The molecular weight of polyglutamic acid is 700,000-1.5 million.

3. The modification method according to claim 1, wherein After the reaction in step (1) is completed, the mixture is precipitated with cyclohexane and dried under reduced pressure to obtain an epoxyalkyl quaternary ammonium salt.

4. The modification method according to claim 1, wherein After the reaction in step (2) is completed, the product is precipitated with ethanol, washed, and vacuum-dried to obtain cationic polyglutamic acid.

5. Cationic polyglutamic acid prepared by the modification method according to claim 1.

6. Use of the cationic polyglutamic acid according to claim 5 in the preparation of cosmetics.

7. The use according to claim 6, characterized in that Cosmetics have whitening effects.

8. The use according to claim 6, characterized in that Cosmetics have anti-aging properties.